30-Second Takeaway
- Multi-ancestry GWASs and CSF biomarker studies sharpen genetic risk prediction for eye disease, stroke, and Alzheimer’s.
- Single-cell eQTL and epigenomic studies expose highly cell-type-specific mechanisms in adipose tissue, airway epithelium, and brain.
- Quantitative functional frameworks refine classification of TP53 hypomorphic alleles, tandem repeats, and recessive enzyme variants.
- Cross-ancestry polygenic and biomarker-based scores move genetic risk stratification closer to clinically actionable thresholds.
- Standardized catalogs and mechanistic models will be essential to translate large-scale functional data into practice-ready variant interpretation.
Week ending April 25, 2026
Genetic architecture, regulatory mechanisms, and quantitative interpretation in complex and Mendelian disease
Multi-ancestry GWAS improves genetic prediction for refractive error and high myopia
In 1.76 million individuals across European, East Asian, and African ancestries, this GWAS identified 932 variants associated with refractive error, including 241 novel loci. Fine-mapping highlighted 16 high-confidence putative causal variants and 23 genes involved in eye development, refining biological targets. An annotation-informed polygenic predictor explained 21.4% of refractive error variance and stratified age of onset, progression, and severity of myopia. The model achieved an AUC of 0.806 for predicting high myopia, suggesting potential for early risk screening across ancestries, pending clinical validation.
Single-cell adipose eQTLs link cardiometabolic and aging risk to 3D chromatin architecture
Single-cell cis-eQTL and colocalization in subcutaneous adipose tissue linked regulatory variants to 279 genes across 33 cardiometabolic and aging traits. Ninety percent of these genes showed cell-type specificity, predominantly in adipocytes, and were largely missed by bulk-tissue colocalization. Epigenomic analyses showed 81% of colocalized risk variants map to active chromatin compartments that comprise only 45% of the genome. These data highlight strongly cell-type- and 3D-chromatin-dependent genetic mechanisms predisposing to obesity-related cardiometabolic disease and accelerated aging.
Low-penetrance TP53 variants behave as hypomorphic alleles with intermediate tumor suppressor function
Using the 2025 UMD_TP53 database, the authors identified missense variants with skewed germline-versus-somatic ratios, consistent with low-penetrance behavior. These high-GVSr variants are enriched in the germline but uncommon as somatic drivers, implying insufficient potency to initiate cancers alone. Multiplexed functional assays and transcriptome analyses showed these variants retain intermediate transcriptional and growth-suppressive activity, classifying them as hypomorphic. This work supports distinguishing hypomorphic low-penetrance TP53 alleles from classic loss-of-function mutations for risk counseling and surveillance planning.
Genetic-anchored mediation implicates DNA methylation as a driver of airway gene expression in asthma
In nasal epithelium from youth with and without asthma, the study evaluated causal directions for 38,562 DNAm–expression eQTM pairs using SNP anchors. Mediation analyses suggested DNA methylation is a plausible causal driver of gene expression in 73% of tested pairs. Genes in these methylation-driven pairs were enriched in immune pathways and associated with asthma phenotypes. Replication of eQTL and meQTL findings in multiple airway and lung tissues underscores DNAm as a potential preventive or therapeutic target in asthma.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.